Literature DB >> 19656205

Hepatoprotective activity of picroliv, curcumin and ellagic acid compared to silymarin on paracetamol induced liver toxicity in mice.

C Girish1, Bidhan Chandra Koner, S Jayanthi, K Ramachandra Rao, B Rajesh, Suresh Chandra Pradhan.   

Abstract

Oxidative stress is implicated as a common pathologic mechanism contributing to the initiation and progression of hepatic damage in a variety of liver disorders. Present study attempts to evaluate the hepatoprotective activity of picroliv, curcumin and ellagic acid in comparison to silymarin using paracetamol (PCM) induced acute liver damage. Hepatotoxicity was induced by administering a single oral dose of PCM (500 mg/kg) and was assessed by quantifying the serum enzyme activities, phenobarbitone induced sleeping time and histopathological analysis of liver tissues. The antioxidant parameters, malondialdehyde (MDA), reduced glutathione (GSH) and catalase of the liver tissue were also assessed. The herbal drugs were administered for 7 days by oral route at 50 and 100 mg/kg. PCM induced hepatic damage was manifested by a significant increase in the activities of marker enzymes (alanine transaminase, aspartate transaminase and alkaline phosphatase) in serum and MDA level in liver. There was also a significant decrease in activity of GSH and catalase levels. The histopathological examination on toxic models revealed centrizonal necrosis and fatty changes. Pretreatment of mice with picroliv, curcumin and ellagic acid reversed these altered parameters towards normal values, which were compared with silymarin. The normalization of phenobarbitone induced sleeping time suggests the restoration of liver cytochrome P450 enzymes. This study supports the use of these active phytochemicals against toxic liver injury, which may act by preventing the lipid peroxidation and augmenting the antioxidant defense system or regeneration of hepatocytes. These active phytochemicals may be developed as drugs for the treatment of liver diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19656205     DOI: 10.1111/j.1472-8206.2009.00722.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  36 in total

1.  Ellagic acid attenuates high-carbohydrate, high-fat diet-induced metabolic syndrome in rats.

Authors:  Sunil K Panchal; Leigh Ward; Lindsay Brown
Journal:  Eur J Nutr       Date:  2012-04-27       Impact factor: 5.614

2.  Ellagic acid reduces methotrexate-induced apoptosis and mitochondrial dysfunction via up-regulating Nrf2 expression and inhibiting the IĸBα/NFĸB in rats.

Authors:  Reihaneh Ebrahimi; Mohammad Reza Sepand; Seyed Afshin Seyednejad; Ameneh Omidi; Mostafa Akbariani; Maryam Gholami; Omid Sabzevari
Journal:  Daru       Date:  2019-11-18       Impact factor: 3.117

3.  Evaluation of some selected herbs on arsenic-affected cattle in Nadia District, West Bengal, India.

Authors:  Jantu M Hazarika; Prasanta K Sarkar; Abichal Chattopadhyay; Tapan K Mandal; Samar Sarkar
Journal:  Environ Sci Pollut Res Int       Date:  2014-12-06       Impact factor: 4.223

4.  Protective effect of pioglitazone, a PPARγ agonist against acetaminophen-induced hepatotoxicity in rats.

Authors:  Gaurav Gupta; Gopala Krishna; Dinesh Kumar Chellappan; Kumar Shiva Gubbiyappa; Mayuren Candasamy; Kamal Dua
Journal:  Mol Cell Biochem       Date:  2014-04-27       Impact factor: 3.396

5.  Protective effects of agmatine against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure in mice.

Authors:  Dina S El-Agamy; Mirhan N Makled; Nareman M Gamil
Journal:  Inflammopharmacology       Date:  2013-08-30       Impact factor: 4.473

6.  Investigation of hepatoprotective activity of Cyathea gigantea (Wall. ex. Hook.) leaves against paracetamol-induced hepatotoxicity in rats.

Authors:  P Madhu Kiran; A Vijaya Raju; B Ganga Rao
Journal:  Asian Pac J Trop Biomed       Date:  2012-05

7.  Ellagic acid ameliorates lung damage in rats via modulating antioxidant activities, inhibitory effects on inflammatory mediators and apoptosis-inducing activities.

Authors:  Abdullah Aslan; Yousif Taha Hussein; Ozlem Gok; Seda Beyaz; Orhan Erman; Serpil Baspinar
Journal:  Environ Sci Pollut Res Int       Date:  2019-12-29       Impact factor: 4.223

8.  Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people.

Authors:  Robert A DiSilvestro; Elizabeth Joseph; Shi Zhao; Joshua Bomser
Journal:  Nutr J       Date:  2012-09-26       Impact factor: 3.271

9.  Effectiveness of ellagic acid on isoniazid-rifampicin induced liver damage in rats.

Authors:  Samuel Stephen Ambrose; Ponnu Solairaj; Appian Subramoniam
Journal:  J Pharmacol Pharmacother       Date:  2013-01

10.  Alternative medicine and anesthesia: Implications and considerations in daily practice.

Authors:  Sukhminder Jit Singh Bajwa; Aparajita Panda
Journal:  Ayu       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.